Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 02/16/2007
Entire Document
 
Table of Contents

 
PRINCIPAL STOCKHOLDERS
 
The following table sets forth information about the beneficial ownership of our common stock at December 31, 2006, and as adjusted to reflect the sale of the shares of common stock in this offering, for:
 
  •      each person known to us to be the beneficial owner of more than 5% of our common stock;
 
  •      each named executive officer;
 
  •      each of our directors; and
 
  •      all of our executive officers and directors as a group.
 
Unless otherwise noted below, the address of each beneficial owner listed on the table is c/o Orexigen Therapeutics, Inc., 12841 High Bluff Drive, Suite 160, San Diego, CA 92130. We have determined beneficial ownership in accordance with the rules of the Securities and Exchange Commission. Except as indicated by the footnotes below, we believe, based on the information furnished to us by the stockholders, that the persons and entities named in the tables below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws. We have based our calculation of the percentage of beneficial ownership “prior to offering” on 37,720,558 shares of common stock outstanding on December 31, 2006, which assumes the conversion of all outstanding shares of preferred stock into common stock, and our calculation of the percentage of beneficial ownership “after offering” on           shares of common stock outstanding upon completion of this offering.
 
In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, we deemed outstanding shares of common stock subject to options held by that person that are currently exercisable or exercisable within 60 days of December 31, 2006. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Beneficial ownership representing less than 1% is denoted with an asterisk (*).
 
                         
          Percentage of
 
    Number of
    Common Stock
 
    Shares
    Beneficially Owned  
    Beneficially
    Prior to
    After
 
Beneficial Owner
  Owned     Offering     Offering  
 
5% or Greater Stockholders:
                       
Funds affiliated with Domain Associates, L.L.C.(1)
    8,047,615       21.3 %     %
One Palmer Square, Suite 515
Princeton, NJ 08542
                       
KPCB Holdings, Inc.(2)
    7,527,615       20.0          
2750 Sand Hill Road
Menlo Park, CA 94025
                       
Funds affiliated with Sofinnova Venture Partners VI, L.P.(3)
    5,645,711       15.0          
140 Geary Street, Tenth Floor
San Francisco, CA 94108
                       
Scale Venture Partners II, LP(4)
    5,594,850       14.8          
950 Tower Lane, Suite 700
Foster City, CA 94404
                       
Funds affiliated with Montreux Equity Partners(5)
    2,797,424       7.4          
3000 Sand Hill Road
Bldg #1, Suite 260
Menlo Park, CA 94025
                       
Morgenthaler Partners VII, L.P.(6)
    2,237,940       5.9          
2710 Sand Hill Road, Suite 100
Menlo Park, CA 94025
                       


110